Smith, Melody Reese
Berry-Kravis, Elizabeth
Thaliath, Andrew
Isenstein, Emily L.
Durkin, Allison R.
Foss-Feig, Jennifer
Siper, Paige M.
Nelson, Charles A.
Baczewski, Lauren
Levin, April R.
Powell, Craig M.
Pulver, Stormi L.
Mosconi, Matthew W.
Kolevzon, Alexander
Ethridge, Lauren E.
Article History
Received: 12 April 2024
Accepted: 17 July 2025
First Online: 25 August 2025
Declarations
:
: The study was approved by the Institutional Review Board (IRB-P00021244 and IRB-P00013300) at Boston Children’s Hospital, which serves as the central IRB for all the sites included in this study. Informed consent was obtained from the legal guardians of all participants and assent was obtained from participants when appropriate.
: Not applicable.
: The authors declare that they have no competing interests with the following exception: CMP, MWM, and LEE each received funding from a Novartis Investigator-initiated Research Award to identify biomarkers associate with PMS from 9/2016 to 8/2019 and funding from the PMS Foundation for phenotyping and natural history studies of PMS.